Back to results
US 8,299,246 B2Granted
N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo-1 (2H)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses
AssigneeAstraZeneca AB
InventorsStephen Brough, Richard Evans, Timothy Jon Luker, Piotr Raubo
Life of this patent
Estimating the term…
Abstract
The present invention relates to pyrazinone derivatives of formula (I): wherein R1, R2, R3, R4, R5, R6 and R7 are as herein defined; processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
Claims4
A compound, or a pharmaceutically acceptable salt thereof, which is N-Cyclopropyl-3-fluoro-5-[3-[[1-[2-[2-[(2-hydroxyethyl)amino]ethoxy]phenyl]cyclopropyl]amino]-2-oxo-1(2H)-pyrazinyl]-4-methyl-benzamide.
Dependencies are inferred from the claim text.